Raia Drogasil S.A.

As of June 30, 2026, Raia Drogasil SA carries a market capitalization of 6.00B, placing it among publicly traded companies globally. Its enterprise value stands at 7.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Raia Drogasil SA's next confirmed earnings release is scheduled for November 3, 2026.

As of June 30, 2026, Raia Drogasil SA has 1.74B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Raia Drogasil SA maintains a current ratio of 1.41, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Raia Drogasil SA recorded 20.55M in income tax expense.

As of the close on October 22, 2026, Raia Drogasil SA's stock has gained approximately 21.23% over the past 52 weeks. The 50-day moving average sits at 3.77, while the 200-day moving average is 4.13.

As of June 30, 2026, Raia Drogasil SA holds 126.32M in cash and equivalents against 1.66B in total debt, resulting in a net debt position of 564.16M. Total book value stands at 1.41B, with working capital of 796.29M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Raia Drogasil SA's most recent stock split took place on December 24, 2025 with a 50:51 split ratio.